Biblio
Export 366 results:
Author Title Type [ Year
Filters: First Letter Of Title is C [Clear All Filters]
“Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 1, pp. 291-301, 2023.
, “Chronic Sleep Disturbances Alters Sleep Structure and Tau Phosphorylation in AβPP/PS1 AD Mice and Their Wild-Type Littermates.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1341-1355, 2023.
, “Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults.”, J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
, “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Cognition and Cognitive Changes in a Low-Income Sub-Saharan African Aging Population.”, J Alzheimers Dis, vol. 95, no. 1, pp. 195-212, 2023.
, “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
, “The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 457-466, 2023.
, “Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.”, J Alzheimers Dis, vol. 91, no. 1, pp. 115-128, 2023.
, “COVID-19 as a Risk Factor for Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
, “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
, “Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?”, J Alzheimers Dis, vol. 87, no. 3, pp. 1079-1087, 2022.
, “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
, “"Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.”, J Alzheimers Dis, vol. 86, no. 2, pp. 787-800, 2022.
, “Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1045-1052, 2022.
, “Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1251-1265, 2022.
, “Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.”, J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
, “Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.”, J Alzheimers Dis, vol. 90, no. 2, pp. 905-915, 2022.
, “Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?”, J Alzheimers Dis, vol. 85, no. 3, pp. 943-955, 2022.
, “Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
, “Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.”, J Alzheimers Dis, vol. 87, no. 2, pp. 771-780, 2022.
, “Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
,